AQEMIA's logo

AQEMIA Stock and Valuation

Pharmaceuticals and Biotechnology
Year Founded
Paris, France

AQEMIA Valuation Estimate

Based on UpMarket valuation model
$4.97 million

AQEMIA Valuation as of Last Funding Round

As of 10/17/19, according to PitchBook Data, Inc.
$4.44 million

Want to buy AQEMIA stock?

UpMarket has helped our customers invest over $140 million into private markets.

AQEMIA Company Overview

Aqemia is a pharmaceutical company utilizing computational chemistry and artificial intelligence to accelerate drug discovery and development. Their innovative approach enables the design of novel molecules with desired properties, optimizing the drug discovery process and reducing time and costs. Aqemia's mission is to revolutionize the pharmaceutical industry and more efficiently bring life-changing medications to patients. Aqemia uses quantum-based physics and AI tools and has become one of the most effective research companies in the world at discovering potential new pharmaceutical drugs for the treatment of a plethora of illnesses.

AQEMIA Valuation History

AQEMIA Stock Price

The stock price of AQEMIA can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.

For illustrative purposes, however, assuming AQEMIA has issued 250 million shares, at the estimated UpMarket valuation of $4.97 million, each share of AQEMIA stock would be worth $0.02.

Buy AQEMIA Stock

If you would like to buy shares in AQEMIA, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”

One of our investor relations team members will contact you to discuss AQEMIA stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.

UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, AQEMIA as well.

AQEMIA Management

Name Position
Maximilien Levesque CEO
Emmanuelle Martiano Co-Founder

AQEMIA Investors




Idinvest Partners

AQEMIA Related Companies

About UpMarket

UpMarket's mission is to unlock the private markets for individual investors.

We provide access to a range of asset classes and investment strategies that span private equity, hedge funds, crypto, real estate, and other alternative assets.

The problem

Historically, accessing private market investments had these challenges:
  • A large barrier to entry due to high investment minimums
  • Time-intensive because sourcing deals is a lot of work even if you’ve got a great network, and
  • Costly because of investment-related diligence costs, paperwork, and legal fees

The solution

UpMarket works to address these barriers for individual investors by:
  • Offering lower investment minimums
  • Sourcing and conducting diligence on opportunities for investors, empowering them to pick and choose from pre-screened opportunities
  • Making the investment process entirely digital, straightforward, and easy to manage from a single portal
Individuals like you have invested over $140 Million with UpMarket.

UpMarket Investment Curation Process

Upmarket curates and conducts diligence on every investment opportunity we offer.

We review every offering’s strategy, risk management, liquidity management, fees and expenses, valuation methodology, tax matters, as well as the fund’s third-party providers including legal counsel, auditor, administrator, and custodian.

We aim to offer our clients investments from disciplined managers that pursue unique strategies across an array of asset classes.

Our goal is to empower you to build a portfolio that best meets your individual Investment objectives.

Unlock the private markets today, with UpMarket.